IL6 and major depressive disorder: In a rat model of chronic unpredictable mild stress (CUMS)-induced depression, epigallocatechin gallate (EGCG) exerted an anti-depressive effect by reducing IL-6 and nitric oxide (NO) expression levels and decreasing the mRNA expression of caspase-3 and caspase-9 in the hippocampus [46].